Kuros Biosciences Ltd. (CSBTF)
24.00
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Kuros Biosciences Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | -10.73M |
| September 30, 2013 | -8.127M |
| June 30, 2013 | -8.638M |
| March 31, 2013 | -5.820M |
| December 31, 2012 | -4.251M |
| September 30, 2012 | -5.419M |
| June 30, 2012 | -2.789M |
| March 31, 2012 | 2.749M |
| December 31, 2011 | -2.903M |
| September 30, 2011 | -7.384M |
| June 30, 2011 | -5.432M |
| March 31, 2011 | -5.646M |
| December 31, 2010 | -6.823M |
| September 30, 2010 | -5.824M |
| June 30, 2010 | |
| March 31, 2010 | -3.604M |
| December 31, 2009 | -1.196M |
| September 30, 2009 | -5.302M |
| June 30, 2009 | -5.566M |
| March 31, 2009 | -10.25M |
| December 31, 2008 | 0.5395M |
| September 30, 2008 | -10.20M |
| June 30, 2008 | -5.279M |
| Date | Value |
|---|---|
| March 31, 2008 | -9.583M |
| December 31, 2007 | -9.011M |
| September 30, 2007 | 19.13M |
| June 30, 2007 | -11.26M |
| March 31, 2007 | -4.633M |
| December 31, 2006 | -6.744M |
| September 30, 2006 | -7.267M |
| June 30, 2006 | -7.084M |
| March 31, 2006 | -6.494M |
| December 31, 2005 | -5.691M |
| September 30, 2005 | -6.356M |
| June 30, 2005 | -3.735M |
| March 31, 2005 | -7.100M |
| December 31, 2004 | -6.163M |
| September 30, 2004 | -5.838M |
| June 30, 2004 | -4.771M |
| March 31, 2004 | -3.260M |
| December 31, 2003 | -4.456M |
| September 30, 2003 | -3.228M |
| June 30, 2003 | -4.671M |
| March 31, 2003 | -4.506M |
| December 31, 2002 | -10.93M |
| September 30, 2002 | -3.408M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Molecular Partners AG | -17.16M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 237.40M |
| AC Immune SA | 2.371M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | 944.14M |
| Earnings Yield | 0.93% |
| Operating Earnings Yield | 1.09% |
| Normalized Earnings Yield | 0.9333 |